basal insulin and glp 1 Glucagon-like peptide (GLP-1) Schematic of action of GLP-1

doi: 10.1210/en.2018-01047 79 VoliotisMPlainZLiXFMcArdleCAO'ByrneKTTsaneva-AtanasovaK

They are extraordinarily stable in terms of reactivity toward other molecules

Animal studies demonstrate minimal fetal exposure, with adverse effects primarily linked to maternal weight loss and reduced food intake rather than direct drug transfer [11,28,29]

Trials of Safety and Efficacy There is now extensive research concerning the efficacy and general safety of the first four DPP-4 inhibitors: sitagliptin, linagliptin, vildagliptin and saxagliptin

But what makes these two GLP-1 medications different

Each batch undergoes analytical testing to ensure high purity and consistency for reliable experimental outcomes